Stevanato Group (NYSE:STVN) Coverage Initiated by Analysts at BNP Paribas

BNP Paribas began coverage on shares of Stevanato Group (NYSE:STVN) in a research report report published on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating on the stock.

Separately, Stephens restated an overweight rating and issued a $38.00 target price on shares of Stevanato Group in a research note on Monday, March 25th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Stevanato Group presently has an average rating of Moderate Buy and an average target price of €33.63 ($35.77).

Stevanato Group Price Performance

NYSE STVN opened at €26.54 ($28.23) on Monday. The company has a fifty day moving average of €30.39 and a two-hundred day moving average of €29.51. The company has a quick ratio of 1.06, a current ratio of 1.50 and a debt-to-equity ratio of 0.23. Stevanato Group has a 52 week low of €23.00 ($24.47) and a 52 week high of €36.30 ($38.62).

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The firm had revenue of €320.60 million during the quarter, compared to analysts’ expectations of €326.85 million. During the same period last year, the company earned $0.19 earnings per share. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, equities analysts predict that Stevanato Group will post 0.67 EPS for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors have recently added to or reduced their stakes in the stock. Trust Point Inc. bought a new stake in shares of Stevanato Group in the 4th quarter valued at about $252,000. Yorktown Management & Research Co Inc purchased a new stake in shares of Stevanato Group during the 4th quarter valued at $254,000. Riverbridge Partners LLC boosted its position in shares of Stevanato Group by 78.1% in the 4th quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock worth $34,789,000 after purchasing an additional 559,070 shares in the last quarter. Raymond James & Associates increased its position in Stevanato Group by 0.9% during the 3rd quarter. Raymond James & Associates now owns 197,316 shares of the company’s stock valued at $5,864,000 after buying an additional 1,806 shares in the last quarter. Finally, Natixis Advisors L.P. boosted its holdings in Stevanato Group by 2.6% in the third quarter. Natixis Advisors L.P. now owns 23,409 shares of the company’s stock worth $696,000 after acquiring an additional 590 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.